Integer Holdings Corp 2025年度季度报告

(Mark One) For the quarterly period endedMarch 28, 2025 16-1531026(I.R.S. Employer Identification No.) (State or other jurisdiction of incorporation or organization) 5830 Granite Parkway,Suite 1150Plano,Texas(Address of principal executive offices) (214)618-5243(Registrant’s telephone number, including area code)Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), Indicate by checkmark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller Large accelerated filer☒AcceleratedfilerSmallerreportingcompany☐Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒ The number of shares outstanding of the Company’s common stock, $0.001 par value per share, as of April18, 2025 was:34,891,995shares. INTEGER HOLDINGS CORPORATIONForm 10-QFor the Quarterly Period Ended March28, 2025 TABLE OF CONTENTS PART I—FINANCIAL INFORMATION ITEM 1.Financial StatementsCondensed Consolidated Balance Sheets (Unaudited)Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)Condensed Consolidated Statements of Cash Flows (Unaudited)Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)Notes to Condensed Consolidated Financial Statements (Unaudited)ITEM 2.Management’s Discussion and Analysis of Financial Condition and Results of OperationsITEM 3.Quantitative and Qualitative Disclosures About Market RiskITEM 4.Controls and Procedures PART II—OTHER INFORMATION PART I—FINANCIAL INFORMATION INTEGER HOLDINGS CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS INTEGER HOLDINGS CORPORATIONNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (1.)BASIS OF PRESENTATION Integer Holdings Corporation (together with its consolidated subsidiaries, “Integer” or the “Company”) is a publicly-tradedcorporation listed on the New York Stock Exchange under the symbol “ITGR.” Integer is a medical device contract development andmanufacturing organization primarily serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Theaccompanyingcondensed consolidated financial statements are presented in accordance with the rules and regulations of theUnited States (“U.S.”) Securities and Exchange Commission (“SEC”)and do not include all of the disclosures normally required byU.S. generally accepted accounting principles (“U.S. GAAP”) as contained in the Company’s Annual Report on Form 10-K. In the opinion of management, the condensed consolidated financial statements reflect all adjustments (consisting of normal recurringadjustments) considered necessary for a fair presentation of the results of the Company for the periods presented. The results forinterim periods are not necessarily indicative of results or trends that may be expected for the fiscal year as a whole.The condensedconsolidated financial statements were prepared using U.S. GAAP, whichrequires management to make estimates and assumptions The first quarters of 2025 and 2024 ended on March28, 2025 and March29, 2024, respectively, and consisted of 87 days and 89 days, Discontinued Operations As discussed in Note 3, “Discontinued Operations,” during 2024 the Company sold Electrochem Solutions, Inc. (“Electrochem”).Electrochem met the criteria to be reported as held for sale and discontinued operations. The results of operations of the Electrochembusiness are classified as discontinued operations and are excluded from continuing operations for all periods presented. Intersegmentsales to Electrochem that were previously eliminated in consolidation have been treated as third party sales and are included in salesfrom continuing operations as the Company will continue to supply the Electrochem business with certain specified productsfollowing its divestiture. The Condensed Consolidated Statements of Cash Flows include cash flows related to the discontinued Factoring Arrangements The Company has receivable factoring arrangements, pursuant to which certain rec